<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="125887">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01682174</url>
  </required_header>
  <id_info>
    <org_study_id>P12-05775</org_study_id>
    <nct_id>NCT01682174</nct_id>
  </id_info>
  <brief_title>Glycaemic Response to a Liquid Meal Tolerance Test</brief_title>
  <official_title>Effects of Dehydrated Vegetable Powder on Glycaemic Responses to a Liquid Meal Tolerance Test (LMTT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mondelēz International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Reading Scientific Services Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mondelēz International, Inc.</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether added food ingredient(s) affect glycaemic
      responses to a liquid meal tolerance test (LMTT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Glycaemic response (incremental area under the curve) of experimental test food using capillary blood</measure>
    <time_frame>120 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Glycaemic Index</condition>
  <condition>Glycaemic Response</condition>
  <arm_group>
    <arm_group_label>Control Test Drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>control drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Test Drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental Drink</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Drink</intervention_name>
    <arm_group_label>Control Test Drink</arm_group_label>
    <arm_group_label>Experimental Test Drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Drink</intervention_name>
    <arm_group_label>Control Test Drink</arm_group_label>
    <arm_group_label>Experimental Test Drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female (not less than 40% Male)

          2. Aged 18 - 55 years

          3. Non Smokers

          4. Have a body mass index between 18.5 to 29.99 kg/m2

          5. Healthy, non-diabetic, no gastric bypass surgery

          6. Not allergic to dairy, or soy

          7. Have a fasting plasma glucose (finger-stick) &lt;100 mg/dl (&lt;5.5 mmol/L)

          8. Willing and able to provide written informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rungano Munyuki</last_name>
    <role>Principal Investigator</role>
    <affiliation>RSSL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Reading Scientific Services Limited (RSSL)</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 7, 2013</lastchanged_date>
  <firstreceived_date>September 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
